Search Results - "Dal Fior, S."

Splenic irradiation in chronic lymphocytic leukemia by Chisesi, T, Capnist, G, Dal Fior, S

“…52 patients with CLL, presenting primarily with splenomegaly, stage II-IV according to the Rai stage system, were treated with a regime of low-dose splenic…”
Get more information

Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trial by Gasparini, G, Dal Fior, S, Panizzoni, G A, Favretto, S, Pozza, F

“…Forty-nine patients with advanced breast cancer who had failed from first-line cyclophosphamide, methotrexate, and 5-fluorouracil (CMF regimen) chemotherapy,…”
Get more information

Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients by Bevilacqua, P, Gasparini, G, Dal Fior, S, Corradi, G

“…Epidermal growth factor (EGF) has been shown to be important in regulating the growth of breast cancer cells in vivo because of its mitogenic action on some…”
Get more information

Synchronous radiotherapy and chemotherapy with cisplatin in the management of locally advanced or recurrent head and neck cancer by Gasparini, G, Recher, G, Testolin, A, Dal Fior, S, Panizzoni, G A, Cristoferi, V, Squaquara, R, Pozza, F

“…A synergism between cisplatin and radiotherapy has been demonstrated in in vitro and in vivo studies. To improve the locoregional control of disease and the…”
Get more information

Conservative surgery and irradiation (QUART) in the treatment of 243 stage I-II breast cancer patients by Gasparini, G, Panizzoni, G A, Dal Fior, S, Germani, B, Dall'Antonia, F, Segato, G, Meli, S, Pozza, F

“…From 1980 to 1987, 243 evaluable patients with pT1, pT2 (less than 3 centimeters in diameter), N0, M0, invasive breast cancer were treated with…”
Get more information

Characterization of node-negative breast cancer by clinico-pathologic and biologic factors by Gasparini, G, Bevilacqua, P, Dal Fior, S, Panizzoni, G A, Favretto, S, Visonà, A, Meli, S

“…About 30% of node-negative breast cancer (NNBC) patients relapse and about 20-25% die after local treatment. This is a heterogenous disease and at present no…”
Get more information

Surgical and adjuvant radiation therapy of resectable retroperitoneal soft tissue sarcomas in adults by Testolin, A, Pozza, F, Dal Fior, S, Bolzicco, G P, Panizzoni, G A, Gasparini, G

“…Primary soft tissue sarcoma of the retroperitoneum is a rare disease. A series of 11 evaluable adult patients with retroperitoneal soft tissue sarcomas is…”
Get more information

Radiotherapeutic treatment for breast cancer choroidal metastases by Panizzoni, G A, Gasparini, G, Dal Fior, S, Pinna, V, Marchetti, C, Pozza, F

“…A series of 14 eyes (11 patients) with choroidal metastases from breast cancer were reported. The lesions were classified into three grades according to the…”
Get more information

156 Accidental over irradiation in breast cancer patients by Dal Fior, S.

“…In the Department of Radiation Therapy Vicenza Hospital, in Italy, where the author was working at the time, in September—october 1989 18 breast cancer…”
Get full text

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study by Rossi, A, Molinari, R, Boracchi, P, Del Vecchio, M, Marubini, E, Nava, M, Morandi, L, Zucali, R, Pilotti, S, Grandi, C

“…To evaluate the effect of adjuvant chemotherapy in patients with local-regional nasopharyngeal carcinoma (NPC) (squamous or undifferentiated) in complete…”
Get more information

A consensus protocol: Image-improved therapeutic guidelines for limited adult Hodgkin's disease by Busetto, Mario, Sotti, Guido, Zorat, Pierluigi, Salvagno, Luigi, Dal Fior, Sandro, Gaion, Fernando, Soraru, Mariella

“…Hodgkin's disease (HD) has greatly benefited from new technologies in terms of less invasive and more accurate staging as well as improved overall and…”
Get full text

464 Incidence and natural history of metastatic adenocarcinoma of the prostate at diagnosis by Dal Fior, S., Iannone, T., D’Incà, G., Guatelli, G., De Marchi, G., Bordin, A., Guazzieri, S.

“…From January 1989 to June 1994, prostatic adenocarcinoma was diagnosed in 139 patients (pts) at the Department of Urology of Belluno Hospital. Thirty-two/139…”
Get full text

Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma by GASPARINI, G, DAL FIOR, S, POZZA, F, BEVILACQUA, P

“…Breast cancer tissue samples obtained from 147 Stage I and II patients were tested with the monoclonal antibody Ki-67 and avidin-biotin-peroxidase complex in…”
Get full text

Simultaneous cis-platinum and radiotherapy in inoperable or locally advanced squamous cell carcinoma of the head and neck by Gasparini, G, Pozza, F, Recher, G, Panizzoni, G A, Cristoferi, V, Squaquara, R, Dal Fior, S

“…A synergism between cis-platinum (CDDP) and radiotherapy (RT) has been demonstrated both in culture systems and in clinical studies. On the above basis, we…”
Get more information

Advanced stages of rectosigmoid cancer. The role of postoperative radiotherapy by Bolzicco, G, Favretto, S, Dal Fior, S, Panizzoni, G A, Pozza, F

“…In patients with advanced rectosigmoid adenocarcinoma treated with radical surgery alone, loco-regional relapse rate is quite high (29%-60%). When…”
Get more information

Phase I study of escalating dose mitoxantrone in combination with α-2-interferon in patients with advanced solid tumors by GASPARINI, G, DAL FIOR, S, POZZA, F, PANIZZONI, G. A, FAVRETTO, S, VON HOFF, D. D

“…In vitro and preclinical in vivo data have shown a synergistic antitumor activity between alpha-interferon and some antiproliferative agents. A phase I study…”
Get full text

Long-term survival in response to combined chemotherapy and radiotherapy in laryngeal small cell carcinoma by Ferlito, A, Pesavento, G, Recher, G, Caruso, G, Dal Fior, S, Montaguti, A, Carraro, R, Narne, S, Pennelli, N

“…Fourteen patients with small cell carcinoma of the larynx are studied. This represents the largest series, from a single institution, reported in the…”
Get more information

Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy by Chisesi, T, Ricciardi, O, Dal Fior, S, Cappellari, F, Pozza, F, Dini, E

“…Eighty-four consecutive, previously untreated patients with stage I, II A-B and IIIA Hodgkin's disease were treated with combined modality therapy including…”
Get more information

Treatment of 49 unrandomized patients with advanced Hodgkin's disease by Chisesi, T, Ricciardi, O, Dal Fior, S, Cappellari, F, Pozza, F, Battista, R, Cortelazzo, S, Capnist, G, D'Emilio, A, Rodeghiero, F

“…Forty-nine patients with previously untreated advanced Hodgkin's disease were treated in our Institution between 1973 and 1981. Treatment modalities of these…”
Get more information

Small size breast cancer conservative surgical therapy and subsequent radiotherapy by Zen, F, Motteran, F, Pigaiani, R, Scicolone, G, Bano, A, Panizzoni, G A, Dal Fior, S, Favretto, S, Bolzicco, B P, Pozza, F

“…From february 1980 to december 1985, 115 breast carcinomas were treated with QU.A.RT. with limited surgery and following radiotherapy. Median age was 51 years…”
Get more information